Sofinnova Ventures targets $600m for eleventh fund

Sofinnova Ventures is seeking to raise $600 million for its eleventh fund, according to an SEC filing. Based in Menlo Park, California, the venture firm targets late preclinical and clinical therapeutic companies across the U.S. and Europe.

Source: SEC filing